Pyoderma gangrenosum is a rare inflammatory skin disease classified within the group of
neutrophilic dermatoses and clinically characterized by painful, rapidly evolving cutaneous …

Psoriasis is an immune-mediated genetic skin disease. The underlying pathomechanisms
involve complex interaction between the innate and adaptive immune system. T cells …

Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease
provoked by autoantibodies directed against two hemidesmosomal proteins: BP180 and …

Abstract Background and Aims Epidemiological studies have established an association
between psoriasis and inflammatory bowel disease [IBD], ie ulcerative colitis [UC] and …

The growing availability of target therapies for psoriasis (biologicals) has dramatically
changed the prognosis of the disease. Currently, the therapeutic goal is represented by a …

New onset or exacerbation of pre-existing psoriasis after therapeutic TNF-α inhibition is a
well-described phenomenon. Over the last two decades, similar cases of paradoxical …

Pyoderma gangrenosum is a challenging disease to manage, due in part to the lack of
approved treatment therapies. Recently, the emergence of biologic agents has expanded …

As aberrant IL-17 signaling plays a critical role in the pathogenesis of psoriasis, biologic
agents targeting this pathway have become an important weapon against this disease …

Abstract Today, anti‐12/IL23, anti‐IL17, and anti‐IL23 provide more efficacious and/or safer
treatment options for psoriasis. Though, anti‐TNF remains a gold standard in the therapy of …

Drug‐induced psoriasiform alopecia is an increasingly recognized form of alopecia mostly
reported in association with TNF‐alpha inhibitors. However, drug‐induced psoriasiform …